CTI BioPharma
- Pharmaceutical Preparations
- Seattle, Washington
Compensation history
Top executives at CTI BioPharma received an average of $2M per person in annual compensation from 2006 to 2019.
Average pay of disclosed executives at CTI BioPharma
By year
- 2018
AC$3MAdam R. CraigPresident, Chief Executive Officer and Interim Chief Medical OfficerJS$1MJack W. SingerFormer Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational MedicineBS$1MBruce J. SeeleyExecutive Vice President, Chief Operating OfficerDK$884KDavid H. KirskeExecutive Vice President, Chief Financial Officer- 2017
AC$6MAdam R. CraigPresident and Chief Executive OfficerBS$1MBruce J. SeeleyExecutive Vice President, Chief Operating OfficerJS$981KJack W. SingerExecutive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational MedicineDK$958KDavid H. KirskeExecutive Vice President, Chief Financial OfficerLB$866KLouis A. BiancoFormer Executive Vice President, Finance and AdministrationMP$743KMatthew PlunkettFormer Executive Vice President, Chief Business OfficerRL$118KRichard L. LoveFormer Interim Chief Executive Officer and President
Executives
We found 15 executives who work or worked at CTI BioPharma.
Adam Craig
CTI BioPharma
Chief Executive Officer
David Kirske
CTI BioPharma
Chief Financial Officer
Bruce Seeley
CTI BioPharma
Chief Operating Officer
Jack Singer
CTI BioPharma
Chief Scientific Officer
Richard Love
CTI BioPharma
Chief Executive Officer
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
Matthew Plunkett
CTI BioPharma
Former Executive Vice President, Chief Business Officer
James Bianco
CTI BioPharma
Chief Executive Officer
News
About CTI BioPharma
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address3101 Western Avenue, Suite 800, Seattle, Washington 98121
- Phone2062827100
- Fiscal year endDecember 31
- Former names
- CELL THERAPEUTICS INCUntil May 28, 2014
Source: SEC filings on April 23, 2020, April 4, 2019, March 30, 2018, March 28, 2017, March 17, 2016, July 29, 2015, March 27, 2014, May 13, 2013, July 27, 2012, October 17, 2011, May 23, 2008, and August 27, 2007.